Impact Biomedical Quote - IBO

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

1.96

Bid

Offer

Volume

23,863

2.08 Day's Range 2.38

1.22 52 Week Range 3.25

Previous Close

2.28

Open

2.27

Last Trade

316

2.14

Last Trade Time

Average Volume (3m)

86,152

Financial Volume

US$ 51,247

VWAP

2.1475

Impact BioMedical Inc. Issues Shareholder Letter Highlighting Recent Achievements and Strategic Vision

HOUSTON, Nov. 19, 2024 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (NYSE American: IBO), a pioneering biotechnology company dedicated to discovering, developing, and patenting innovative...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Impact BioMedical Inc. Announces Issuance of Canadian Patent for Linebacker™ Technology Targeting Inflammatory Disease

HOUSTON, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (NYSE: IBO), is thrilled to announce a significant milestone in its innovative Linebacker™ technology platform. The Canadian...

Form 8-K - Current report

Impact BioMedical Inc. (NYSE American: IBO) Announces IPO Participation with Strong Support from Partners and Affiliates

HOUSTON, Oct. 07, 2024 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (NYSE American: IBO), a pioneering biotechnology company dedicated to discovering, developing, and patenting innovative...

Impact BioMedical Inc. (NYSE: IBO) Announces 3F™ US Patent Issue

HOUSTON, Sept. 26, 2024 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (“IBO”) is pleased to announce that the US Patent and Trademark Office has issued U.S. Patent No. 11,985,973 entitled “Insect...

Impact BioMedical Inc. Introduces Leadership Team to Drive Innovation and Growth

NEW YORK, Sept. 23, 2024 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (NYSE American: IBO), a pioneering biotechnology company dedicated to discovering, developing, and patenting unique healthcare...

Form 8-K - Current report

Impact BioMedical Inc. Announces the Closing of its Initial Public Offering

NEW YORK, Sept. 17, 2024 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (NYSE American: IBO), a company discovering and developing new offerings in human healthcare and wellness, today announced...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.87	-30.74204947	2.83	2.95	1.96	35034	2.45333742	CS
4	-0.84	-30	2.8	3.25	1.96	52947	2.74583947	CS
12	-1.04	-34.6666666667	3	3.25	1.22	86152	2.29921339	CS
26	-1.04	-34.6666666667	3	3.25	1.22	86152	2.29921339	CS
52	-1.04	-34.6666666667	3	3.25	1.22	86152	2.29921339	CS
156	-1.04	-34.6666666667	3	3.25	1.22	86152	2.29921339	CS
260	-1.04	-34.6666666667	3	3.25	1.22	86152	2.29921339	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
UAMYUnited States Antimony Corp	US$ 1.895 (40.37%)	20.28M
GPUSHyperscale Data Inc	US$ 6.79 (36.35%)	647.91k
CHROChannel Therapeutics Corporation	US$ 0.8349 (26.31%)	1.09M
ROLRHigh Roller Technologies Inc	US$ 6.60 (16.40%)	29.63k
DSSDSS Inc	US$ 1.04 (12.95%)	93.24k
CTMCastellum Inc	US$ 0.28675 (-18.07%)	6.51M
PWPower REIT	US$ 1.90 (-16.30%)	1.06M
UMACUnusual Machines Inc	US$ 8.66 (-15.51%)	4.17M
UAVSAgEagle Aerial Systems Inc	US$ 5.735 (-14.40%)	1.82M
SCPXScorpius Holdings Inc	US$ 0.3978 (-13.75%)	515.71k
MSTZT Rex 2X Inverse MSTR Daily Target ETF	US$ 0.9556 (-4.11%)	613.28M
SOXLDirexion Daily Semiconductor Bull 3X Shares	US$ 29.61 (1.68%)	48.61M
NVDQT Rex 2X Inverse NVIDIA Daily Target ETF	US$ 3.165 (3.77%)	39.89M
TZADirexion Daily Small Cap Bear 3X Share New	US$ 10.485 (-1.08%)	30.4M
SPYSPDR S&P 500	US$ 607.81 (0.19%)	30.32M